Стан показників ейкозаноїдів у хворих на генералізований пародонтит
Юрій Іванович Силенко, Марина Вікторівна Хребор, Наталія Миколаївна Копельян et al. · Український стоматологічний альманах · 2011
The given research fixed that the patients with generalized periodontitis of the II stage occur the increase of level 6-keto PGF1α (14,8±0,5 pg/ml) in their blood 2 times more . ТХВ2 concentration also exceeded norm 3,6 times more (18,0±0,7 pg/ml vs 5,0±0,26 pg/ml). 6-keto PGF1α/ТХВ2 index reduced 2,2 times . Generalized periodontitis exacerbation is characterized by the activation of lipoxygenase pathway of arachidonic acid metabolism which is in its turn characterized 5,2 times more LTB4 concentration increase. After the conducted treatment 6-keto PGF1α and ТХВ2 levels exceeded in the patients the same values of the screening group 1,2 and 1,6 times more , PG Е2 and PGF2α were also higher ( 1,3 and 1,8 times more correspondingly). LTB4 concentration after the treatment exceeded the indices of the screening group 1,7 times more as well. PGO application for the treatment of the patients with generalized periodontitis had higher corrective effect for the eicosanoids indices as compared with the traditional treatment methods. All these factors allow recommending the application of the suggested treatment method in clinical practice.
Cited by 0 works.